Diligence memo · auto-generated · as of July 2, 2026
Effcon MXR LLC
Effcon MXR LLC looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Effcon MXR LLC operates in Pharmaceuticals, based in ATLANTA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Effcon MXR LLC has raised $6.5M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on —.
Most recent recorded round closed around 2009-10-30.
Valuation (modeled)modeled
Provath models Effcon MXR LLC at approximately $34M (range $404K–$387M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.42× the median modeled value of Seed Pharmaceuticals companies in 2007–2009 (25 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 119 months.
Last raise 16.7 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 47% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 35% of those peers.
Closest niche peers: Sequoia Pharmaceuticals Inc, Spring Pharmaceuticals, LLC, Oceana Therapeutics, Inc., Supergen Inc, Archer Pharmaceuticals, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.